Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid
- PMID: 3413812
- DOI: 10.1161/01.str.19.9.1140
Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid
Abstract
Neuron-specific enolase concentrations were measured in samples of rat cerebrospinal fluid obtained repeatedly before and after occlusion of the middle cerebral artery. A method for reliable, repeated sampling of cisternal cerebrospinal fluid was developed for this purpose. Occlusion of the middle cerebral artery induced cerebral infarcts of slightly variable size with good correlation to raised neuron-specific enolase concentrations. Sham operation caused only superficial cortical damage at the site of surgery and was followed by an early, slight, and transient increase in neuron-specific enolase concentration. With our technique, the development of cerebral infarcts can be studied in individual rats under experimentally controlled conditions over an extended period of time. Analysis of neuron-specific enolase can be used in trials of drugs for mitigating the effect of ischemia. Information concerning the release of neuron-specific enolase from ischemic cerebral tissue to the cerebrospinal fluid is important because neuron-specific enolase in the cerebrospinal fluid can be determined in patients suffering from cerebrovascular insult.
Similar articles
-
CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model.Brain Res. 1992 Apr 17;577(2):249-52. doi: 10.1016/0006-8993(92)90280-m. Brain Res. 1992. PMID: 1606499
-
Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease.Med Pregl. 2003 Jul-Aug;56(7-8):326-32. doi: 10.2298/mpns0308326s. Med Pregl. 2003. PMID: 14587248 English, Serbian.
-
[Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke].Neurol Neurochir Pol. 1989 May-Jun;23(3):198-202. Neurol Neurochir Pol. 1989. PMID: 2634819 Polish.
-
Cerebrospinal fluid enolase in stroke.J Neurol Neurosurg Psychiatry. 1984 Jul;47(7):724-9. doi: 10.1136/jnnp.47.7.724. J Neurol Neurosurg Psychiatry. 1984. PMID: 6747647 Free PMC article.
-
[The possibility of using neuron-specific enolase as a biomarker in the acute period of stroke].Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(8. Vyp. 2):53-62. doi: 10.17116/jnevro201911908253. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31825363 Review. Russian.
Cited by
-
Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat.Acta Neurochir (Wien). 1994;129(3-4):188-92. doi: 10.1007/BF01406503. Acta Neurochir (Wien). 1994. PMID: 7847162
-
The significance of neuron specific enolase levels in cerebrospinal fluid and serum after experimental traumatic brain damage.Acta Neurochir (Wien). 1995;135(3-4):141-3. doi: 10.1007/BF02187758. Acta Neurochir (Wien). 1995. PMID: 8748804
-
Biomarkers for acute diagnosis and management of stroke in neurointensive care units.Brain Circ. 2016 Jan-Mar;2(1):28-47. doi: 10.4103/2394-8108.178546. Epub 2016 Mar 11. Brain Circ. 2016. PMID: 30276272 Free PMC article. Review.
-
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.Metab Brain Dis. 2016 Jun;31(3):487-95. doi: 10.1007/s11011-016-9801-6. Epub 2016 Feb 5. Metab Brain Dis. 2016. PMID: 26847611 Free PMC article. Review.
-
Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope.J Neurol. 2010 Oct;257(10):1708-12. doi: 10.1007/s00415-010-5608-2. Epub 2010 Jun 8. J Neurol. 2010. PMID: 20532546
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources